Company / Operating Cash Flow
Moderna Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$1.9B
FY2025
5-year range
-$3.1B / $2.0B
FY2021-FY2025
Trend
+37.6%
vs FY2024
Sector context
#216 of 216
Health Care
What the data says
Among 216 Health Care companies, Moderna is in the bottom 0% for operating cash flow. Operating Cash Flow has fluctuated over the past 10 years, ranging from -$3.1B in FY2023 to $2.0B in FY2022.
Based on SEC 10-K filings.
-$1.9B in FY2025.
Improved from -$3.1B to -$1.9B over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 216This company -$1.9B Sector average $658.7M
▼
-384.3% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow increased 37.6% year-over-year.
- Ranks #216 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2022.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.9B | +37.6% |
| FY2024 | -$3.0B | +3.7% |
| FY2023 | -$3.1B | -253.8% |
| FY2022 | $2.0B | +541.6% |
| FY2021 | -$459.0M | -122.6% |
| FY2020 | $2.0B | +541.6% |
| FY2019 | -$459.0M | -38.7% |
| FY2018 | -$330.9M | +0.2% |
| FY2017 | -$331.5M | -596.7% |
| FY2016 | $66.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026